Details for New Drug Application (NDA): 086586
✉ Email this page to a colleague
NDA 086586 describes BELIX, which is a drug marketed by Halsey and is included in one NDA. Additional details are available on the BELIX profile page.
The generic ingredient in BELIX is diphenhydramine hydrochloride. There are twenty-three drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.
The generic ingredient in BELIX is diphenhydramine hydrochloride. There are twenty-three drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.
Summary for 086586
| Tradename: | BELIX |
| Applicant: | Halsey |
| Ingredient: | diphenhydramine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 086586
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | ELIXIR;ORAL | Strength | 12.5MG/5ML | ||||
| Approval Date: | Oct 3, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
